QQQ   281.98 (-0.05%)
AAPL   146.40 (+0.21%)
MSFT   249.20 (+0.13%)
META   138.98 (-0.93%)
GOOGL   101.43 (-0.21%)
AMZN   120.95 (-0.12%)
TSLA   240.81 (-3.46%)
NVDA   132.09 (+0.32%)
NIO   16.04 (-4.12%)
BABA   84.39 (+0.33%)
AMD   67.94 (+0.06%)
T   15.93 (-0.99%)
MU   54.73 (+1.43%)
CGC   3.07 (-2.23%)
F   12.51 (+1.21%)
GE   67.44 (-0.15%)
DIS   100.80 (-0.63%)
AMC   7.33 (-6.39%)
PYPL   93.83 (+1.12%)
PFE   44.12 (-0.76%)
NFLX   236.73 (-1.67%)
QQQ   281.98 (-0.05%)
AAPL   146.40 (+0.21%)
MSFT   249.20 (+0.13%)
META   138.98 (-0.93%)
GOOGL   101.43 (-0.21%)
AMZN   120.95 (-0.12%)
TSLA   240.81 (-3.46%)
NVDA   132.09 (+0.32%)
NIO   16.04 (-4.12%)
BABA   84.39 (+0.33%)
AMD   67.94 (+0.06%)
T   15.93 (-0.99%)
MU   54.73 (+1.43%)
CGC   3.07 (-2.23%)
F   12.51 (+1.21%)
GE   67.44 (-0.15%)
DIS   100.80 (-0.63%)
AMC   7.33 (-6.39%)
PYPL   93.83 (+1.12%)
PFE   44.12 (-0.76%)
NFLX   236.73 (-1.67%)
QQQ   281.98 (-0.05%)
AAPL   146.40 (+0.21%)
MSFT   249.20 (+0.13%)
META   138.98 (-0.93%)
GOOGL   101.43 (-0.21%)
AMZN   120.95 (-0.12%)
TSLA   240.81 (-3.46%)
NVDA   132.09 (+0.32%)
NIO   16.04 (-4.12%)
BABA   84.39 (+0.33%)
AMD   67.94 (+0.06%)
T   15.93 (-0.99%)
MU   54.73 (+1.43%)
CGC   3.07 (-2.23%)
F   12.51 (+1.21%)
GE   67.44 (-0.15%)
DIS   100.80 (-0.63%)
AMC   7.33 (-6.39%)
PYPL   93.83 (+1.12%)
PFE   44.12 (-0.76%)
NFLX   236.73 (-1.67%)
QQQ   281.98 (-0.05%)
AAPL   146.40 (+0.21%)
MSFT   249.20 (+0.13%)
META   138.98 (-0.93%)
GOOGL   101.43 (-0.21%)
AMZN   120.95 (-0.12%)
TSLA   240.81 (-3.46%)
NVDA   132.09 (+0.32%)
NIO   16.04 (-4.12%)
BABA   84.39 (+0.33%)
AMD   67.94 (+0.06%)
T   15.93 (-0.99%)
MU   54.73 (+1.43%)
CGC   3.07 (-2.23%)
F   12.51 (+1.21%)
GE   67.44 (-0.15%)
DIS   100.80 (-0.63%)
AMC   7.33 (-6.39%)
PYPL   93.83 (+1.12%)
PFE   44.12 (-0.76%)
NFLX   236.73 (-1.67%)
NASDAQ:OFIX

Orthofix Medical - OFIX Stock Forecast, Price & News

$19.43
-0.16 (-0.82%)
(As of 10/5/2022 12:00 AM ET)
Add
Compare
Today's Range
$19.04
$19.52
50-Day Range
$19.08
$25.90
52-Week Range
$18.97
$38.83
Volume
138,298 shs
Average Volume
111,504 shs
Market Capitalization
$386.89 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$45.00

Orthofix Medical MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
131.6% Upside
$45.00 Price Target
Short Interest
Healthy
2.38% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.48mentions of Orthofix Medical in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
2.22%
From $0.45 to $0.46 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.26 out of 5 stars

Medical Sector

385th out of 1,072 stocks

Surgical & Medical Instruments Industry

41st out of 103 stocks

OFIX stock logo

About Orthofix Medical (NASDAQ:OFIX) Stock

Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions, as well as markets regenerative non-tissue biologic solutions derived from synthetic materials. The Global Orthopedics segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Receive OFIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Orthofix Medical and its competitors with MarketBeat's FREE daily newsletter.

OFIX Stock News Headlines

OFIX Orthofix Medical Inc.
Orthofix Medical (NASDAQ:OFIX) Issues FY 2022 Earnings Guidance
Orthofix Reports Second Quarter 2022 Results
Foot And Ankle Devices Global Market Report 2022
See More Headlines
Receive OFIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Orthofix Medical and its competitors with MarketBeat's FREE daily newsletter.

OFIX Company Calendar

Last Earnings
8/05/2022
Today
10/05/2022
Next Earnings (Estimated)
11/04/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:OFIX
CUSIP
N6748L10
Employees
1,087
Year Founded
1980

Price Target and Rating

Average Stock Price Forecast
$45.00
High Stock Price Forecast
$45.00
Low Stock Price Forecast
$45.00
Forecasted Upside/Downside
+131.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-38,380,000.00
Pretax Margin
-2.92%

Debt

Sales & Book Value

Annual Sales
$464.48 million
Cash Flow
$3.19 per share
Book Value
$16.99 per share

Miscellaneous

Free Float
19,215,000
Market Cap
$386.89 million
Optionable
Optionable
Beta
1.03

Social Links


Key Executives

  • Mr. Jon C. SerbousekMr. Jon C. Serbousek (Age 61)
    Pres, CEO & Director
    Comp: $1.61M
  • Mr. Douglas C. Rice (Age 56)
    CFO & Chief Accounting Officer
    Comp: $782.49k
  • Ms. Kimberley A. EltingMs. Kimberley A. Elting (Age 57)
    Chief Legal & Devel. Officer and Pres of the Global Orthopedics
    Comp: $781.15k
  • Mr. Kevin J. Kenny (Age 57)
    Pres of Global Spine Bus.
    Comp: $778.96k
  • Mr. Roberto Donadello
    Sr. VP of Global Operations
  • Dr. James T. Ryaby B.A. (Age 63)
    Chemistry, Ph.D., Chief Scientific Officer
  • Mr. Dan E. Yarbrough
    VP of Investor Relations
  • Ms. Suzanne Armstrong
    VP of HR
  • Mr. Ehab M. Esmail (Age 50)
    Sr. VP of Quality, Regulatory & Clinical Affairs
  • Mr. Dalles Stiles
    Sr. VP of Strategy













OFIX Stock - Frequently Asked Questions

Should I buy or sell Orthofix Medical stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" OFIX shares.
View OFIX analyst ratings
or view top-rated stocks.

What is Orthofix Medical's stock price forecast for 2022?

1 Wall Street analysts have issued 12-month price objectives for Orthofix Medical's stock. Their OFIX share price forecasts range from $45.00 to $45.00. On average, they predict the company's share price to reach $45.00 in the next year. This suggests a possible upside of 134.3% from the stock's current price.
View analysts price targets for OFIX
or view top-rated stocks among Wall Street analysts.

How have OFIX shares performed in 2022?

Orthofix Medical's stock was trading at $31.09 at the start of the year. Since then, OFIX shares have decreased by 38.2% and is now trading at $19.21.
View the best growth stocks for 2022 here
.

When is Orthofix Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, November 4th 2022.
View our OFIX earnings forecast
.

How were Orthofix Medical's earnings last quarter?

Orthofix Medical Inc. (NASDAQ:OFIX) announced its quarterly earnings data on Friday, August, 5th. The medical device company reported $0.08 earnings per share for the quarter, beating analysts' consensus estimates of $0.07 by $0.01. The medical device company had revenue of $118.07 million for the quarter, compared to analyst estimates of $117.40 million. Orthofix Medical had a negative net margin of 8.00% and a positive trailing twelve-month return on equity of 1.90%.

What guidance has Orthofix Medical issued on next quarter's earnings?

Orthofix Medical updated its FY 2022 earnings guidance on Friday, September, 2nd. The company provided earnings per share guidance of $0.45-$0.55 for the period. The company issued revenue guidance of $455.00 million-$465.00 million, compared to the consensus revenue estimate of $479.18 million.

What is Brad Mason's approval rating as Orthofix Medical's CEO?

32 employees have rated Orthofix Medical Chief Executive Officer Brad Mason on Glassdoor.com. Brad Mason has an approval rating of 73% among the company's employees.

What other stocks do shareholders of Orthofix Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthofix Medical investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Edwards Lifesciences (EW), Gilead Sciences (GILD), Biogen (BIIB), Pfizer (PFE), Exxon Mobil (XOM), Advanced Micro Devices (AMD), bluebird bio (BLUE) and Esperion Therapeutics (ESPR).

What is Orthofix Medical's stock symbol?

Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX."

Who are Orthofix Medical's major shareholders?

Orthofix Medical's stock is owned by a number of retail and institutional investors. Top institutional investors include Moody National Bank Trust Division (0.17%). Insiders that own company stock include Catherine M Burzik, James F Hinrichs, Jon Carl Serbousek, Kimberley A Elting, Michael E Paolucci, Rice Doug and Ronald A Matricaria.
View institutional ownership trends
.

How do I buy shares of Orthofix Medical?

Shares of OFIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Orthofix Medical's stock price today?

One share of OFIX stock can currently be purchased for approximately $19.21.

How much money does Orthofix Medical make?

Orthofix Medical (NASDAQ:OFIX) has a market capitalization of $382.47 million and generates $464.48 million in revenue each year. The medical device company earns $-38,380,000.00 in net income (profit) each year or ($1.86) on an earnings per share basis.

How many employees does Orthofix Medical have?

The company employs 1,087 workers across the globe.

How can I contact Orthofix Medical?

Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The official website for the company is www.orthofix.com. The medical device company can be reached via phone at (214) 937-2000, via email at markquick@orthofix.com, or via fax at 599 9 461 6978.

This page (NASDAQ:OFIX) was last updated on 10/5/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.